Literature DB >> 2007940

Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging.

F van Bel1, G L Guit, J Schipper, M van de Bor, J Baan.   

Abstract

Renal dysfunction has been recognized as an adverse effect of indomethacin treatment and is probably secondary to impairment of renal blood flow. We therefore evaluated renal artery blood flow velocity in 15 premature infants with a symptomatic ductus arteriosus before and during the first 12 hours after a single intravenous dose of 0.1 mg/kg of indomethacin. Renal artery blood flow velocity was measured serially by color-Doppler flow imaging and used as a qualitative measure of true renal blood flow. Indomethacin administration led to a sharp decrease in peak systolic flow velocity and temporal mean flow velocity of the renal artery. This effect was maximal at 10 minutes after indomethacin dosing; the flow velocities showed a slow recovery, reaching baseline values again at 2 hours after indomethacin dosing. We conclude that indomethacin can affect renal blood supply in the premature infant for a period of at least 1 hour after indomethacin treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007940     DOI: 10.1016/s0022-3476(05)83391-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

Review 1.  Diuretics in pediatrics : current knowledge and future prospects.

Authors:  Maria M J van der Vorst; Joana E Kist; Albert J van der Heijden; Jacobus Burggraaf
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

2.  Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin.

Authors:  R C Coombs; M E Morgan; G M Durbin; I W Booth; A S McNeish
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

3.  Superior mesenteric artery and renal artery blood flow velocity measurements in neonates: technique and interobserver reliability.

Authors:  F J Weir; K Fong; M L Ryan; T Myhr; A Ohlsson
Journal:  Pediatr Radiol       Date:  1995

4.  Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus.

Authors:  Gozde Kanmaz; Omer Erdeve; Fuat Emre Canpolat; Serife Suna Oğuz; Nurdan Uras; Nahide Altug; Ben Greijdanus; Uğur Dilmen
Journal:  Eur J Clin Pharmacol       Date:  2012-11-06       Impact factor: 2.953

Review 5.  Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.

Authors:  Manoj N Malviya; Arne Ohlsson; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

6.  Treatment of patent ductus arteriosus with ibuprofen.

Authors:  B Van Overmeire; I Follens; S Hartmann; W L Creten; K J Van Acker
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-05       Impact factor: 5.747

7.  Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.

Authors:  Karen E Corff; Kris C Sekar
Journal:  J Pediatr Pharmacol Ther       Date:  2007-07

Review 8.  Management of acute kidney injury in children: a guide for pediatricians.

Authors:  Sharon P Andreoli
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

9.  Effect of oral ibuprofen on patent ductus arteriosus in premature newborns.

Authors:  Sabry Ghanem; Mansour Mostafa; Mohamed Shafee
Journal:  J Saudi Heart Assoc       Date:  2010-03-10

Review 10.  Acute kidney injury in children.

Authors:  Sharon Phillips Andreoli
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.